Literature DB >> 687489

Use of 129caesium, 99Tcm stannous pyrophosphate, and a combination of the two in the assessment of myocardial infarction.

S Walton, E Kafetzakis, R A Shields, H J Testa, D J Rowlands.   

Abstract

Acutely damaged myocardium was shown in 103 patients with suspected acute myocardial infarction using 99Tcm pyp. A significant incidence of false positive and false negative results occurred, 'true' results being defined by standard clinical, electrocardiographic, and enzyme criteria. Localisation of infarction compared reasonably well with standard electrocardiographic criteria but more frequently suggested true posterior involvement. Serial estimates of infarct size may be of value in the recognition of infarct extension during the acute phase. Viable perfused myocardium was shown in 63 patients with a variety of cardiac disorders using 129Cs. The technique gives a reliable indication of anterior infarction but tends to underestimate inferior infarction. There was good correlation with the electrocardiogram with regard to localisation and extent of infarction. Nineteen patients received both isotopes and were included in each of the above groups. The combination permits further assessment of equivocal results Furthermore as 129Cs demonstrates both previous and recent infarction and 99Tcm pyp accumulates only in acutely damaged myocardium it was possible to estimate the extent of previous and recent myocardial damage.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 687489      PMCID: PMC483502          DOI: 10.1136/hrt.40.8.874

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  24 in total

1.  A new method of diagnosing myocardial contusion in man by radionuclide imaging.

Authors:  R T Go; B D Doty; C L Chiu; J H Christie
Journal:  Radiology       Date:  1975-07       Impact factor: 11.105

2.  Cardioversion and "false positive" technetium-99m stannous pyrophosphate myocardial scintigrams.

Authors:  B R Pugh; L M Buja; R W Parkey; L R Poliner; E M Stokely; F J Bonte; J T Willerson
Journal:  Circulation       Date:  1976-09       Impact factor: 29.690

3.  A new method for radionuclide imaging of acute myocardial infarction in humans.

Authors:  R W Parkey; F J Bonte; S L Meyer; J M Atkins; G L Curry; E M Stokely; J T Willerson
Journal:  Circulation       Date:  1974-09       Impact factor: 29.690

4.  A new method for radionuclide imaging of myocardial infarcts.

Authors:  F J Bonte; R W Parkey; K D Graham; J Moore; E M Stokely
Journal:  Radiology       Date:  1974-02       Impact factor: 11.105

5.  Mitochondrial mineralization in human myocardium.

Authors:  A N D'Agostino; M Chiga
Journal:  Am J Clin Pathol       Date:  1970-06       Impact factor: 2.493

6.  Technetium 99m stannous pyrophosphate myocardial imaging in patients with and without left ventricular aneurysm.

Authors:  M Ahmad; J P Dubiel; T A Verdon; R H Martin
Journal:  Circulation       Date:  1976-05       Impact factor: 29.690

7.  Intense myocardial uptake of 99mTc-diphosphonate in a uremic patient with secondary hyperparathyroidism and pericarditis: case report.

Authors:  W R Janowitz; A D Serafini
Journal:  J Nucl Med       Date:  1976-10       Impact factor: 10.057

8.  Limitations of thallium-201 myocardial perfusion scintigrams.

Authors:  T M Mueller; M L Marcus; J C Ehrhardt; T Chaudhuri; F M Abboud
Journal:  Circulation       Date:  1976-10       Impact factor: 29.690

9.  Localization of 99mTc-Sn-pyrophosphate in left ventricular aneurysms.

Authors:  R J Kelly; R J Cowan; C D Maynard; R N Headley; F R Kahl
Journal:  J Nucl Med       Date:  1977-04       Impact factor: 10.057

10.  Acute myocardial infarction imaged with 99mTc-stannous pyrophosphate and 201Tl: a clinical evaluation.

Authors:  R W Parkey; F J Bonte; E M Stokely; S E Lewis; K D Graham; L M Buja; J T Willerson
Journal:  J Nucl Med       Date:  1976-09       Impact factor: 10.057

View more
  1 in total

Review 1.  Non-invasive assessment of the effects of drugs on acute myocardial infarct size in man.

Authors:  D Maclean
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.